A recent study showed that co-targeting mTOR and PD-L1 enhances tumor control by increasing the IFNγ production capacity in peripheral and tumor-infiltrating CD8 T cells in a syngeneic oral cavity cancer model [109]. The gene discussed is CD8A; the disease is neoplasm.